122 related articles for article (PubMed ID: 12862135)
1. Safety and immunogenicity of an autoclaved Leishmania major vaccine.
Khalil EA; Elhassan AM; Zijlstra EE; Osman OF; Eljack IA; Ibrahim ME; Mukhtar MM; Ghalib HW; Modabbers F
East Afr Med J; 2000 Sep; 77(9):468-70. PubMed ID: 12862135
[TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of a candidate vaccine for visceral leishmaniasis (Alum-precipitated autoclaved Leishmania major + BCG) in children: an extended phase II study.
Khalil EA; Musa AM; Modabber F; El-Hassan AM
Ann Trop Paediatr; 2006 Dec; 26(4):357-61. PubMed ID: 17132302
[TBL] [Abstract][Full Text] [Related]
3. Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan.
Khalil EA; El Hassan AM; Zijlstra EE; Mukhtar MM; Ghalib HW; Musa B; Ibrahim ME; Kamil AA; Elsheikh M; Babiker A; Modabber F
Lancet; 2000 Nov; 356(9241):1565-9. PubMed ID: 11075771
[TBL] [Abstract][Full Text] [Related]
4. Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment.
Musa AM; Khalil EA; Mahgoub FA; Elgawi SH; Modabber F; Elkadaru AE; Aboud MH; Noazin S; Ghalib HW; El-Hassan AM;
Trans R Soc Trop Med Hyg; 2008 Jan; 102(1):58-63. PubMed ID: 17963805
[TBL] [Abstract][Full Text] [Related]
5. Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran.
Sharifi I; FeKri AR; Aflatonian MR; Khamesipour A; Nadim A; Mousavi MR; Momeni AZ; Dowlati Y; Godal T; Zicker F; Smith PG; Modabber F
Lancet; 1998 May; 351(9115):1540-3. PubMed ID: 10326536
[TBL] [Abstract][Full Text] [Related]
6. Alum-precipitated autoclaved Leishmania major plus bacille Calmette-Guérrin, a candidate vaccine for visceral leishmaniasis: safety, skin-delayed type hypersensitivity response and dose finding in healthy volunteers.
Kamil AA; Khalil EA; Musa AM; Modabber F; Mukhtar MM; Ibrahim ME; Zijlstra EE; Sacks D; Smith PG; Zicker F; El-Hassan AM
Trans R Soc Trop Med Hyg; 2003; 97(3):365-8. PubMed ID: 15228261
[TBL] [Abstract][Full Text] [Related]
7. The role of BCG in human immune responses induced by multiple injections of autoclaved Leishmania major as a candidate vaccine against leishmaniasis.
Alimohammadian MH; Khamesipour A; Darabi H; Firooz A; Malekzadeh S; Bahonar A; Dowlati Y; Modabber F
Vaccine; 2002 Dec; 21(3-4):174-80. PubMed ID: 12450691
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and safety of autoclaved Leishmania major plus BCG vaccine in healthy Sudanese volunteers.
Satti IN; Osman HY; Daifalla NS; Younis SA; Khalil EA; Zijlstra EE; El Hassan AM; Ghalib HW
Vaccine; 2001 Feb; 19(15-16):2100-6. PubMed ID: 11228382
[TBL] [Abstract][Full Text] [Related]
9. A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran.
Momeni AZ; Jalayer T; Emamjomeh M; Khamesipour A; Zicker F; Ghassemi RL; Dowlati Y; Sharifi I; Aminjavaheri M; Shafiei A; Alimohammadian MH; Hashemi-Fesharki R; Nasseri K; Godal T; Smith PG; Modabber F
Vaccine; 1999 Feb; 17(5):466-72. PubMed ID: 10073725
[TBL] [Abstract][Full Text] [Related]
10. Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis.
Armijos RX; Weigel MM; Calvopina M; Hidalgo A; Cevallos W; Correa J
Vaccine; 2004 Mar; 22(9-10):1320-6. PubMed ID: 15003662
[TBL] [Abstract][Full Text] [Related]
11. Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-Shahr district, I.R. Iran.
Mohebali M; Khamesipour A; Mobedi I; Zarei Z; Hashemi-Fesharki R
Vaccine; 2004 Sep; 22(29-30):4097-100. PubMed ID: 15364462
[TBL] [Abstract][Full Text] [Related]
12. Immune response measured in human volunteers vaccinated with autoclaved Leishmania major vaccine mixed with low dose of BCG.
Mahmoodi M; Khamesipour A; Dowlati Y; Rafati S; Momeni AZ; Emamjomeh M; Hejazi H; Modabber F
Clin Exp Immunol; 2003 Nov; 134(2):303-8. PubMed ID: 14616791
[TBL] [Abstract][Full Text] [Related]
13. Failure of a killed Leishmania amazonensis vaccine against American cutaneous leishmaniasis in Colombia.
Vélez ID; Gilchrist K; Arbelaez MP; Rojas CA; Puerta JA; Antunes CM; Zicker F; Modabber F
Trans R Soc Trop Med Hyg; 2005 Aug; 99(8):593-8. PubMed ID: 15893351
[TBL] [Abstract][Full Text] [Related]
14. Field trial of a vaccine against new world cutaneous leishmaniasis in an at-risk child population: how long does protection last?
Armijos RX; Weigel MM; Romero L; Garcia V; Salazar J
J Infect Dis; 2003 Jun; 187(12):1959-61. PubMed ID: 12792873
[TBL] [Abstract][Full Text] [Related]
15. The adjuvant effects of IL-12 and BCG on autoclaved Leishmania major vaccine in experimental cutaneous leishmaniasis.
Michel MY; Fathy FM; Hegazy EH; Hussein ED; Eissa MM; Said DE
J Egypt Soc Parasitol; 2006 Apr; 36(1):159-76, following 76. PubMed ID: 16605109
[TBL] [Abstract][Full Text] [Related]
16. [Concordance of leishmaniasis cutaneous tests in Tunisia].
Ben Alaya Bouafif N; Ben Salah A; Louzir H; Zaâtour A; Bel Haj Hamida N; Mighri F; Gharbi A; Gramiccia M; Gradoni L; Dellagi K; Ben Ismaïl R
Arch Inst Pasteur Tunis; 2001; 78(1-4):11-6. PubMed ID: 14658234
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic potential of autoclaved Leishmania donovani with BCG against experimental visceral leishmaniasis.
Srivastava JK; Misra A; Sharma P; Srivastava B; Naik S; Dube A
Parasitology; 2003 Aug; 127(Pt 2):107-14. PubMed ID: 12954011
[TBL] [Abstract][Full Text] [Related]
18. Visceral leishmaniasis in southeastern Nepal: a cross-sectional survey on Leishmania donovani infection and its risk factors.
Schenkel K; Rijal S; Koirala S; Koirala S; Vanlerberghe V; Van der Stuyft P; Gramiccia M; Boelaert M
Trop Med Int Health; 2006 Dec; 11(12):1792-9. PubMed ID: 17176343
[TBL] [Abstract][Full Text] [Related]
19. Double-Blind Randomized Efficacy Field Trial of Alum Precipitated Autoclaved Leishmania major (Alum-ALM) Vaccine Mixed With BCG Plus Imiquimod Vs. Placebo Control Group.
Barati M; Mohebali M; Alimohammadian MH; Khmesipour A; Keshavarz H; Akhoundi B; Zarei Z
Iran J Parasitol; 2015; 10(3):351-9. PubMed ID: 26622290
[TBL] [Abstract][Full Text] [Related]
20. A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis.
Chakravarty J; Kumar S; Trivedi S; Rai VK; Singh A; Ashman JA; Laughlin EM; Coler RN; Kahn SJ; Beckmann AM; Cowgill KD; Reed SG; Sundar S; Piazza FM
Vaccine; 2011 Apr; 29(19):3531-7. PubMed ID: 21414377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
